Surgepays is trading 34.11% down now at $0.16 after its second-quarter report disclosed substantial doubt about continuing as a going concern.
- Reported a $21.3 million working-capital deficit and insufficient cash for obligations over the next 12 months.
- Q2 revenue rose 40.7% to $16.2 million, but profitability included a non-recurring $8.51 million settlement gain.
- Shares had already closed August 19, 2026, down 8.31% at $0.25.